DJIA 17,387.21 -291.49 -1.65%
NASDAQ 4,681.50 -90.27 -1.89%
S&P 500 2,029.55 -27.54 -1.34%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

62.56 -0.26 (-0.41%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $62.56 -0.41%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $62.88
Previous Close $62.82
Daily Range $62.13 - $63.02
52-Week Range $51.78 - $63.62
Market Cap $178.4B
P/E Ratio 34.14
Dividend (Yield) $1.80 (2.9%)
Ex-Dividend Date
Dividend Pay Date
12/11/14
01/08/15
Volume 7,964,680
Average Daily Volume 11,220,487
Current FY EPS $3.48

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary

This Popular Beverage Could Be Responsible For a 20% Reduction in Melanoma Risk

The good news: this beverage reduced the risk of an aggressive form of skin cancer by 20% in a very large study. The better news: 83% of you are already consuming this beverage on a daily basis!

Fast Money Halftime Report Final Trade From January 27

White House Budget To Support Biotech Rally

Dow Analyst Moves: MRK

Broker Darlings Of The Dow: Merck Ranks As A Top 15 Analyst Pick

Advaxis: Legit Reasons to Take Another Look at Under-Appreciated Cancer Immunotherapy

Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog

Roche Earnings Preview: Oncology Drugs And Tamiflu Will Help The Revenue Growth

One Put, One Call Option To Know About for Merck & Co.

A New Price Estimate Now That Afrezza Is Launching

See More MRK News...

MRK's Top Competitors

MRK $62.56 (-0.41%)
Current stock: MRK
JNJ $102.09 (-0.17%)
Current stock: JNJ
NVS $98.93 (2.53%)
Current stock: NVS
RHHBY $35.70 (0.63%)
Current stock: RHHBY